KRM Ayurveda Ltd. (KRMAYURVED-SM): KRM Ayurveda Share Price Falls 9.73% to Rs 297.7 as Micro Cap Stock Trends Among Top Decliners

KRM Ayurveda Ltd. traded at Rs 297.7, down 9.73% today, with market capitalisation at Rs 701.18 crore and turnover of Rs 7.83 crore on NSE.

KRM Ayurveda Share Price came under pressure on 11 August 2026, with the stock falling to Rs 297.7, down Rs 32.1 or 9.73% from the previous close of Rs 329.8. With a market capitalisation of Rs 701.18 crore, KRM Ayurveda Ltd. moved into focus in Stock Market Today because the decline was large enough to place the healthcare counter among the notable top decliner names on the NSE.

The session data shows a clear weakening in intraday price action. The stock opened at Rs 333, touched a high of Rs 334, and then slid to a day low of Rs 297.7, which also matched the current traded price at the time of the data snapshot. That pattern suggests the KRM Ayurveda Share Price Today lost ground steadily through the session rather than recovering meaningfully from lower levels. Turnover stood at Rs 7.83 crore, while total traded volume was 2,63,000 shares, all reported on NSE.

For investors tracking KRM Ayurveda Stock News, the verified data confirms the price fall and confirms that the stock qualified for this event as a Micro Cap name. The supplied data establishes what happened in price and trading activity, but it does not establish a company-specific catalyst behind the move. That makes today’s KRM Ayurveda Share Price Update primarily a price-action-led event, with investors now likely to weigh valuation, profitability, peer positioning and sector context more closely. In this Univest analysis, the focus is on what the numbers show, what they do not show, and what investors should monitor next.

KRM Ayurveda Ltd. (KRMAYURVED-SM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 297.7
Previous Close	Rs 329.8
Today's Change	Rs -32.1 (-9.73%)
Day Open	Rs 333
Day High	Rs 334
Day Low	Rs 297.7
Current Volume (NSE)	2,63,000
NSE Traded Volume	2,63,000
Combined NSE + BSE Volume	2,63,000
Turnover	Rs 7.83 crore
Market Capitalisation	Rs 701.18 crore
Market Cap Category	Micro Cap

KRM Ayurveda Ltd. (KRMAYURVED-SM) traded at Rs 297.7. versus the previous close of Rs 329.8, a fall of 9.73%. The stock opened at Rs 333, reached Rs 334, touched Rs 297.7. Reported volume was 2,63,000.

KRM Ayurveda Ltd. (KRMAYURVED-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 701.18 crore
P/E Ratio	34.85x
P/B Ratio	15.59x
ROE	90.82%
ROCE	37.67%
EPS	Rs 9.46
Dividend Yield	0%

KRM Ayurveda Ltd. was valued at a P/E ratio of 34.85x, a P/B ratio of 15.59x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 90.82% and ROCE of 37.67%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 9.46, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

KRM Ayurveda Fundamental Analysis shows a company that combines a relatively small market size with striking profitability ratios and demanding valuation multiples. The company’s market capitalisation stands at Rs 701.18 crore, placing it in the micro-cap bracket, while the share is trading at a price-to-earnings ratio of 34.85 and a price-to-book ratio of 15.59. Those are important figures because they shape how investors interpret today’s price fall against the business’s existing valuation backdrop.

On profitability, the supplied numbers are strong. Return on equity is 90.82%, while return on capital employed is 37.67%. ROE at 90.82% indicates a very high level of earnings generation relative to shareholder equity, and ROCE at 37.67% points to strong returns on capital employed. At the same time, the P/B ratio of 15.59 is elevated in absolute terms, meaning the market has been assigning a substantial premium to the company’s book base. That combination of high profitability and high valuation can make a stock especially sensitive to price swings when market sentiment changes.

EPS also adds important context. Earnings per share stand at Rs 9.46, which helps explain the basis of the 34.85 P/E multiple at the current stock price. Dividend yield is 0, which means the current data does not show a cash yield component supporting the stock. In practical terms, that places even greater emphasis on business performance, earnings quality and market valuation when investors assess the KRM Ayurveda Share Price Fall.

The market cap of Rs 701.18 crore is not a quality signal by itself, but it does matter for liquidity and volatility. Smaller companies can sometimes see sharper moves when buying or selling pressure intensifies. For readers following KRM Ayurveda Stock Analysis, today’s decline does not by itself alter the company’s reported P/E, P/B, ROE, ROCE or EPS figures, but it does make those figures more central to the discussion. In Univest’s view, the supplied fundamentals suggest that investor attention is understandable: KRM Ayurveda Ltd. is not a low-valuation story, yet it is also not a weak-profitability story based on the reported numbers. That tension becomes clearer when the stock is placed against its Healthcare industry benchmark.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	34.85x
Benchmark Median P/E	27.3x
Benchmark Average P/E	218.45x
Benchmark P/E Range	7.37x to 2,992.36x
Company P/B Ratio	15.59x
Benchmark Median P/B	2.06x
Company ROE	90.82%
Benchmark Median ROE	14.66%
Company ROCE	37.67%
Benchmark Median ROCE	18.85%
Company Market Capitalisation	Rs 701.18 crore
Benchmark Median Market Cap	Rs 103.36 crore

KRM Ayurveda Ltd. (KRMAYURVED-SM) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

KRM Ayurveda Ltd. (KRMAYURVED-SM) has a P/E ratio of 34.85x, which is above the benchmark median of 27.3x, a difference of +27.66%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

KRM Ayurveda Ltd. (KRMAYURVED-SM) has a ROE of 90.82%, which is above the benchmark median of 14.66%, a difference of +519.51%. KRM Ayurveda Ltd. (KRMAYURVED-SM) has a ROCE of 37.67%, which is above the benchmark median of 18.85%, a difference of +99.84%.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

KRM Ayurveda operates in the Healthcare sector and the Hospital & Healthcare Services industry. Against the supplied same-industry benchmark of 40 companies, the stock’s valuation and profitability profile looks unusual: its P/E is above the median, its P/B is at the top end of the range, and its ROE and ROCE are well above typical benchmark levels.

The sector snapshot gives a useful frame for interpreting KRM Ayurveda Share Price. The benchmark scope is the same industry, covering 40 companies in Hospital & Healthcare Services. KRM Ayurveda Ltd. has a company P/E of 34.85. That stands above the industry median P/E of 27.3 but far below the average of 218.45, an average that appears heavily influenced by outliers because the benchmark range runs from 7.37 to 2,992.36 across 33 companies with available P/E data. So, relative to the median, the stock is priced at a premium, though not near the extreme top of the industry’s full valuation spread.

The price-to-book comparison is more striking. KRM Ayurveda’s P/B is 15.59, while the same-industry median is 2.06 and the average is 2.75 across 40 companies. The benchmark minimum is -9.79 and the maximum is 15.59, which means KRM Ayurveda is sitting at the upper bound of the supplied P/B range. That is a notable data point for anyone following KRM Ayurveda Share Price Today and valuation sensitivity.

Profitability metrics are stronger than the industry’s central tendency. Company ROE is 90.82%, versus a benchmark median of 14.66% and average of 36.33% across 40 companies. Company ROCE is 37.67%, versus a median of 18.85% and average of 21.42%. Market-cap context is also relevant: KRM Ayurveda’s Rs 701.18 crore market capitalisation is above the industry median of Rs 103.36 crore and above the average of Rs 448.99 crore, though still far below the benchmark maximum of Rs 2,601.85 crore. Univest reads this mix as a company with above-benchmark profitability, above-median size within the industry set, and a distinctly premium balance-sheet valuation.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,601.85	34.14	7.04	-2.6	16.92
KMC Speciality Hospitals (India) Ltd.	KMCSHIL	1,900.76	40.67	9.03	22.42	25.85
Krsnaa Diagnostics Ltd.	KRSNAA	1,831.49	17.92	1.85	0	129.09
Shalby Ltd.	SHALBY	1,733.02	15.49	1.4	5.19	6.85
SURAKSHA DIAGNOSTIC LIMITED	SURAKSHA	1,302.54	40.62	5.54	13.93	22.94

KRM Ayurveda Ltd. (KRMAYURVED-SM) has a P/E ratio of 34.85x compared with the displayed peer median of 34.14x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 90.82% compares with a peer median of 5.19% across the companies shown in the table. ROCE stood at 37.67% versus the displayed peer median of 22.94%, providing a capital-efficiency comparison. KRM Ayurveda Ltd. (KRMAYURVED-SM) has a market capitalisation of Rs 701.18 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

KRM Ayurveda’s peer set in Hospital & Healthcare Services shows a wide spread in valuation and profitability. Relative to these listed companies, KRM Ayurveda has a smaller market cap than every supplied peer, but its ROE is among the strongest and its P/B multiple is richer than the peer group figures shown.

Looking at the supplied peers, Dr Agarwals Eye Hospital Ltd. has a market cap of Rs 2,601.85 crore, P/E of 34.14, P/B of 7.04, ROE of -2.6%, and ROCE of 16.92. KMC Speciality Hospitals (India) Ltd. stands at Rs 1,900.76 crore market cap with P/E of 40.67, P/B of 9.03, ROE of 22.42%, and ROCE of 25.85. Krsnaa Diagnostics Ltd. carries a Rs 1,831.49 crore market cap, P/E of 17.92, P/B of 1.85, ROE of 0, and ROCE of 129.09. Shalby Ltd. is at Rs 1,733.02 crore with P/E of 15.49, P/B of 1.4, ROE of 5.19%, and ROCE of 6.85.

Further down the peer list, SURAKSHA DIAGNOSTIC LIMITED has a market cap of Rs 1,302.54 crore, P/E of 40.62, P/B of 5.54, ROE of 13.93%, and ROCE of 22.94. GPT Healthcare Ltd. stands at Rs 1,299.75 crore with P/E of 27.3, P/B of 4.57, ROE of 33.06%, and ROCE of 25.56. Unihealth Hospitals Ltd. is valued at Rs 1,230.66 crore with P/E of 46.58, P/B of 8.83, ROE of 29.75%, and ROCE of 20.33. Gujarat Kidney N Sup Sp L shows Rs 1,059.65 crore market cap with P/E of 67.82, P/B of 4.16, ROE of 26.56%, and ROCE of 36.31, while Gaudium IVF N Women H L stands at Rs 953.51 crore with P/E of 38.21, P/B of 6.14, ROE of 94.99%, and ROCE of 82.39.

Against these numbers, KRM Ayurveda Ltd. at Rs 701.18 crore market cap is the smallest among the supplied peers. Its P/E of 34.85 is broadly in the mid-pack, close to Dr Agarwals Eye Hospital and above GPT Healthcare and Shalby, but below Unihealth, Gujarat Kidney and KMC Speciality. Its ROE of 90.82% is among the strongest in the peer sample, second only to Gaudium IVF N Women H L at 94.99%. ROCE of 37.67% is stronger than several peers, though below Krsnaa Diagnostics at 129.09 and Gaudium IVF at 82.39. The outlier is P/B at 15.59, which is above every peer figure supplied here, reinforcing the point that the market has been assigning KRM Ayurveda a very premium book-value multiple.

Why Investors Are Watching KRM Ayurveda

KRM Ayurveda Share Price is being watched because today’s decline was large, the stock finished at its session low, and the valuation-versus-profitability mix is not straightforward. The move has also stood out within Market News because the company sits in the Healthcare space with premium valuation markers and unusually high return ratios.

• Price action: The stock fell 9.73% from Rs 329.8 to Rs 297.7, after opening at Rs 333 and touching a high of Rs 334 before sliding to its low.
• Trading activity: NSE and total volume were both 2,63,000 shares, with turnover of Rs 7.83 crore.
• Market-cap context: KRM Ayurveda Ltd. is classified as a Micro Cap company with market capitalisation of Rs 701.18 crore.
• Fundamental profile: P/E is 34.85, P/B is 15.59, ROE is 90.82%, ROCE is 37.67%, EPS is Rs 9.46, and dividend yield is 0.
• Sector positioning: P/E is above the industry median of 27.3, while P/B is at the benchmark maximum of 15.59.

What investors may monitor next is whether KRM Ayurveda Share Price stabilises after today’s decline, how the premium valuation is judged against the strong reported ROE and ROCE, and whether the stock’s position relative to Healthcare peers changes meaningfully. As Univest notes, the data confirms a sharp price fall and a premium multiple structure, but not a verified company-specific trigger for the session’s weakness.

About KRM Ayurveda

KRM Ayurveda Ltd. is being classified in the supplied market data under the Healthcare sector and the Hospital & Healthcare Services industry. That industry classification matters because it determines the benchmark set used for valuation and profitability comparisons and places the company alongside listed hospital and diagnostics-related businesses for market analysis purposes.

From an investor’s perspective, the most relevant company overview available in the supplied data is its place within this listed healthcare services universe. The company’s market capitalisation is Rs 701.18 crore, which makes it smaller than all nine supplied listed peers but still above the same-industry median market cap of Rs 103.36 crore and above the average of Rs 448.99 crore. That indicates that KRM Ayurveda is not one of the very smallest names in the benchmark set, even though it remains a micro-cap stock in the broader market classification used for this event.

The stock’s financial market profile is defined by a P/E of 34.85, P/B of 15.59, ROE of 90.82%, ROCE of 37.67%, EPS of Rs 9.46 and dividend yield of 0. In practical terms, that means the market has valued the company at a premium to book value while the reported return ratios remain very strong. For readers following KRM Ayurveda Share News, that combination helps explain why the company can stay on investors’ radar even during sessions marked by price falls and weak momentum in the stock price itself.

Track KRM Ayurveda Share Price on Univest

Use KRM Ayurveda Ltd. (KRMAYURVED-SM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors who want to follow KRM Ayurveda Share Price more closely can track the stock on Univest for live share price movement, daily stock updates and broader market context. A single price fall does not provide the complete picture, so it helps to monitor both real-time price action and the underlying valuation ratios together.

On Univest, users can follow KRM Ayurveda Share Price Today alongside market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, dividend yield, 52-week levels, peer positioning and sector comparison. The platform also helps users place KRM Ayurveda Stock News within the larger Healthcare and Indian Stock Market context. For investors comparing micro-cap names, Univest can be useful for tracking market movers, stock performance and data-led stock analysis without turning a one-day move into a long-term conclusion.

Frequently Asked Questions

Why is KRM Ayurveda Share Price in focus today?

Ans. KRM Ayurveda Share Price is in focus because the stock fell 9.73% in a single session to Rs 297.7 from the previous close of Rs 329.8, making it one of the notable top decliner names tracked in today’s market data.

What is KRM Ayurveda Share Price Today?

Ans. KRM Ayurveda Share Price Today is Rs 297.7 at the supplied data snapshot. The stock was down Rs 32.1 on the day, after trading between an intraday high of Rs 334 and a low of Rs 297.7 on NSE.

How much did KRM Ayurveda stock fall today?

Ans. KRM Ayurveda stock declined by Rs 32.1, or 9.73%, compared with its previous close of Rs 329.8. The current traded price in the supplied data is Rs 297.7, which also matches the session low recorded.

What does today’s price action show for KRM Ayurveda?

Ans. The stock opened at Rs 333, moved up to Rs 334, and then weakened sharply to Rs 297.7. Since the current price equals the day low, the session data shows sustained intraday selling pressure rather than a late recovery.

What is the market capitalisation of KRM Ayurveda Ltd.?

Ans. KRM Ayurveda Ltd. has a market capitalisation of Rs 701.18 crore in the supplied data. That places it in the Micro Cap category for this event, even though it stands above the industry median market cap of Rs 103.36 crore.

What valuation ratios does KRM Ayurveda currently trade at?

Ans. KRM Ayurveda currently trades at a P/E ratio of 34.85 and a P/B ratio of 15.59. The P/E is above the industry median of 27.3, while the P/B is at the top end of the supplied same-industry benchmark range.

How profitable is KRM Ayurveda based on reported ratios?

Ans. The supplied data shows ROE of 90.82% and ROCE of 37.67%, both comfortably above the same-industry medians of 14.66% and 18.85%. EPS is Rs 9.46, indicating the per-share earnings base behind the current P/E multiple.

Does KRM Ayurveda pay a dividend?

Ans. The current dividend yield shown for KRM Ayurveda is 0. That means the supplied market data does not show a dividend yield contribution at the present price, making valuation and profitability ratios more central to analysis.

How active was trading in KRM Ayurveda shares today?

Ans. Trading activity reached 2,63,000 shares on NSE, with total volume also at 2,63,000 shares. Turnover stood at Rs 7.83 crore, which is notable activity for a stock with market capitalisation of Rs 701.18 crore.

How does KRM Ayurveda compare with listed healthcare peers?

Ans. KRM Ayurveda is smaller than all supplied peers by market cap at Rs 701.18 crore, but its ROE of 90.82% is among the strongest. Its P/B of 15.59 is also higher than every peer value listed in the data.